Aim Immunotech Stock Probability of Future Stock Price Finishing Under 0.22
| AIM Stock | USD 0.22 0.01 4.29% |
AIM |
AIM ImmunoTech Target Price Odds to finish below 0.22
The tendency of AIM Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.22 | 90 days | 0.22 | about 15.3 |
Based on a normal probability distribution, the odds of AIM ImmunoTech to move below current price in 90 days from now is about 15.3 (This AIM ImmunoTech probability density function shows the probability of AIM Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon AIM ImmunoTech has a beta of 0.79. This suggests as returns on the market go up, AIM ImmunoTech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AIM ImmunoTech will be expected to be much smaller as well. Additionally AIM ImmunoTech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. AIM ImmunoTech Price Density |
| Price |
Predictive Modules for AIM ImmunoTech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AIM ImmunoTech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AIM ImmunoTech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AIM ImmunoTech is not an exception. The market had few large corrections towards the AIM ImmunoTech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AIM ImmunoTech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AIM ImmunoTech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.6 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.12 |
AIM ImmunoTech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AIM ImmunoTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AIM ImmunoTech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AIM ImmunoTech generated a negative expected return over the last 90 days | |
| AIM ImmunoTech has high historical volatility and very poor performance | |
| AIM ImmunoTech has some characteristics of a very speculative penny stock | |
| AIM ImmunoTech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 202 K. Reported Net Loss for the year was (28.96 M) with loss before taxes, overhead, and interest of (715 K). | |
| AIM ImmunoTech has about 27.05 M in cash with (21.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| AIM ImmunoTech has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: AIMs Clinical Strategy Under Incumbent Board Has Totally Failed |
AIM ImmunoTech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AIM Stock often depends not only on the future outlook of the current and potential AIM ImmunoTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AIM ImmunoTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 13.1 M |
AIM ImmunoTech Technical Analysis
AIM ImmunoTech's future price can be derived by breaking down and analyzing its technical indicators over time. AIM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AIM ImmunoTech. In general, you should focus on analyzing AIM Stock price patterns and their correlations with different microeconomic environments and drivers.
AIM ImmunoTech Predictive Forecast Models
AIM ImmunoTech's time-series forecasting models is one of many AIM ImmunoTech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AIM ImmunoTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AIM ImmunoTech
Checking the ongoing alerts about AIM ImmunoTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AIM ImmunoTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AIM ImmunoTech generated a negative expected return over the last 90 days | |
| AIM ImmunoTech has high historical volatility and very poor performance | |
| AIM ImmunoTech has some characteristics of a very speculative penny stock | |
| AIM ImmunoTech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 202 K. Reported Net Loss for the year was (28.96 M) with loss before taxes, overhead, and interest of (715 K). | |
| AIM ImmunoTech has about 27.05 M in cash with (21.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| AIM ImmunoTech has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: AIMs Clinical Strategy Under Incumbent Board Has Totally Failed |
Check out AIM ImmunoTech Backtesting, AIM ImmunoTech Valuation, AIM ImmunoTech Correlation, AIM ImmunoTech Hype Analysis, AIM ImmunoTech Volatility, AIM ImmunoTech History as well as AIM ImmunoTech Performance. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.004 | Quarterly Revenue Growth 0.19 | Return On Assets (0.80) | Return On Equity (1.55) |
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.